2024
Health correlates of experiential and behavioral avoidance among trauma-exposed veterans
Schwartz E, Palmisano A, Petrakis I, Pietrzak R, Sofuoglu M. Health correlates of experiential and behavioral avoidance among trauma-exposed veterans. Journal Of Psychiatric Research 2024, 176: 213-217. PMID: 38878649, DOI: 10.1016/j.jpsychires.2024.06.014.Peer-Reviewed Original ResearchTrauma-exposed veteransExperiential avoidanceBehavioral avoidanceAnxiety symptomsDepressive symptomsMental health outcomesCognitive dysfunctionPhysical healthPhysical health outcomesHealth outcomesQuality of lifeHealth-related dysfunctionTrauma historyPsychosocial functioningCognitive functionAvoidance behaviorOutcome measuresHealth-related quality of lifeTreatment targetDistressExploratory analysisVeteransHealth-related qualityAvoidanceAnxiety
2022
Modafinil does not reduce cocaine use in methadone-maintained individuals
DeVito EE, Poling J, Babuscio T, Nich C, Carroll KM, Sofuoglu M. Modafinil does not reduce cocaine use in methadone-maintained individuals. Drug And Alcohol Dependence Reports 2022, 2: 100032. PMID: 36310662, PMCID: PMC9615926, DOI: 10.1016/j.dadr.2022.100032.Peer-Reviewed Original ResearchCocaine use disorderCocaine use outcomesOpioid useCognitive behavioral therapyContingency managementCocaine dependenceCognitive functionMethadone-maintained individualsUse outcomesEfficacy of modafinilSelf-reported abstinenceTreatment of CUDStimulant-like effectsPlatform treatmentPercentage of urinesPercent of daysDual opioidModafinil treatmentUse disordersPotential efficacyCocaine useModafinilPlaceboMinimal reportsBehavioral therapy
2019
Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder
DeVito EE, Carroll KM, Babuscio T, Nich C, Sofuoglu M. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal Of Substance Use And Addiction Treatment 2019, 107: 29-37. PMID: 31757262, PMCID: PMC6918721, DOI: 10.1016/j.jsat.2019.08.009.Peer-Reviewed Original ResearchConceptsCocaine use disorderSignificant treatment group differencesUse disordersEfficacy of galantamineTreatment-seeking cocaine usersCurrent cocaine use disordersGroup differencesCocaine use outcomesSample of individualsTreatment group differencesComorbid opioid use disorderMethadone-maintained individualsMemory capacityAbstinent individualsCocaine useCognitive improvementCognitive outcomesCocaine use reductionCognitive functionUse outcomesCocaine usersGalantamine groupIndividualsDisordersInitial promise
2017
Neurocognitive Function as a Treatment Target for Tobacco Use Disorder
Robinson C, Waters A, Kang N, Sofuoglu M. Neurocognitive Function as a Treatment Target for Tobacco Use Disorder. Current Behavioral Neuroscience Reports 2017, 4: 10-20. DOI: 10.1007/s40473-017-0105-x.Peer-Reviewed Original ResearchCognitive processesTobacco use disorderAutomatic cognitive processesExecutive cognitive processesApproach-avoidance taskTranscranial direct current stimulationUse disordersDirect current stimulationExecutive processesAutomatic cognitionCognitive improvementCognitive functionNeurocognitive functionCurrent stimulationDistinct literaturesFuture researchTreatment targetsCognitionFurther researchDisordersRecent FindingsThereResearchBeneficial effectsTaskSmall samples
2014
Chapter Twelve Cognitive Effects of Nicotine
Sofuoglu M, Herman A, Robinson C, Waters A. Chapter Twelve Cognitive Effects of Nicotine. 2014, 367-385. DOI: 10.1016/b978-0-12-418679-8.00012-5.Peer-Reviewed Original ResearchCognitive-enhancing effectsPrefrontal cortexCognitive functionCognitive deficitsEpisodic memory performanceFine motor skillsNicotine addictionMemory performanceCognitive effectsMotor skillsEffects of nicotineIndividual factorsNicotine administrationFlexibility functionMemoryCortexDeficitsAddictionΑ7 nicotinic acetylcholine receptorEffective treatment strategiesNicotinic acetylcholine receptorsNicotineRelease of neurotransmittersΑ4β2Cigarette smoking